American Association for the Study of Liver Diseases 2012
The American Association for the Study of Liver Diseases 63rd Annual Meeting, also known as The Liver Meeting Â®, â€œis the largest gathering of hepatologists in the world, providing unparalleled access to groundbreaking research, new treatment guidelines, and the latest advances in the field of hepatology.â€ This yearâ€™s meeting will be held in Boston, Massachusetts, November 9-13. The main website for The Liver Meeting Â® says that, for some clinicians, this conference â€œis the forum for an elite group of liver specialists to discuss and debate the year's most relevant, cutting-edge research. For others, it is a series of courses and workshops for clinicians to learn the most effective ways to treat their patients.
The development of direct acting antivirals has led to significant improvement in treatment outcomes for many patients with hepatitis C. New research has also improved management of treatment-related anemia, helped streamline standard therapy, and identified promising new approaches to interferon-free treatment.
Treatment with Direct-acting Antivirals Achieves Sustained Virologic Response in Patients with Hepatitis C